VivaVision to advance non-steroidal therapy in Phase III following Phase II win
The company’s non-steroidal immunomodulator met the primary endpoint in a Phase II trial as a treatment for post-op inflammation following cataract surgery.
Spyre Therapeutics begins dosing subjects in Phase I trials of anti-TL1A antibodies
Parents urged to vaccinate children in wake of UK pneumonia epidemic
Gate Neurosciences and Pitt commence antidepressant drug trial
Medical firms urged not to let assumptions put patients at risk
Arrowhead seeks approval to begin RNAi therapy trial for obesity treatment
Analysis
View More
Themes
View MoreMerus’ Bizengri granted FDA accelerated approval to treat NRG1+ cancers
The FDA has granted accelerated approval to Bizengri in the treatment of advanced, unresectable NG1+ lung and pancreatic cancers.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Four oral GLP-1R products in Phase III trials as race intensifies
Lead Gilead researcher highlights need for inclusive clinical trials for HIV
Dr Oz nominated to lead CMS despite big pharma ties
Yonalink launches ICTN to position Israel as leader in clinical trial innovation